SciHub
文献互助
期刊查询
一搜即达
科研导航
交流社区
登录
注册
发布
文献
求助
首页
我的求助
捐赠本站
yyyrocket
Lv1
1
20 积分
2022-12-26 加入
最近求助
最近应助
互助留言
Discovery of ARS-1620 analogs as KRas G12C inhibitors with high in vivo antitumor activity
6小时前
待确认
A four-component domino reaction for the synthesis of novel bridgehead nitrogen-containing pyrido[1,2-d][1,4]diazepines
2天前
已完结
Identification of the Clinical Development Candidate MRTX849, a Covalent KRASG12C Inhibitor for the Treatment of Cancer
12天前
已完结
Functional Characterization and Protein Engineering of a Triterpene 3‐/6‐/2′‐O‐Glycosyltransferase Reveal a Conserved Residue Critical for the Regiospecificity
12天前
已完结
KRAS: From undruggable to a druggable Cancer Target
19天前
已完结
Tumor Growth Inhibition-Overall Survival (TGI-OS) Model for Subgroup Analysis Based on Post-Randomization Factors: Application for Anti-drug Antibody (ADA) Subgroup Analysis of Atezolizumab in the IMpower150 Study
21天前
已完结
Associations between the uptake of 111In-DTPA-trastuzumab, HER2 density and response to trastuzumab (Herceptin) in athymic mice bearing subcutaneous human tumour xenografts
21天前
已完结
KRAS: From undruggable to a druggable Cancer Target
22天前
已完结
Selenium and human health
1个月前
已完结
In Silico Prediction of Human Intravenous Pharmacokinetic Parameters with Improved Accuracy
2个月前
已完结
没有进行任何应助
想要正文,不要proof
4个月前
已找到【积分已退回】
5个月前
不想要Pre-proof
10个月前
感谢
10个月前
不想要Journal Pre-proof,想要正刊,感谢
1年前
想要见刊版本
1年前
是不是只有Pre-proof呀
1年前
感谢,帮大忙了
1年前
速度真快,感谢
1年前
速度真快,帮大忙了
1年前
最近帖子
最近评论
没有发布任何帖子
没有发布任何评论